OTC · Biotechnology

Finch Therapeutics Group, Inc. (FNCH) Stock

$9.60 -3.71% OTC: FNCH Healthcare

Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.

Valuation

MetricValue
Price$9.60
Market Cap$15.42M
P/E Ratio-1.11
P/B Ratio1.70
P/S Ratio0.00
EPS (TTM)$-8.64
52-Week High$16.10
52-Week Low$2.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-86.83%
ROA-27.89%
ROCE-40.49%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity3.06
Current Ratio3.39

Annual Financials (USD)

Metric20202021202220232024
Revenue$8.0M$19.0M$1.0M$0$0
Operating Profit$-39.0M$-60.0M$-95.0M$-34.0M$-19.0M
Net Profit$-39.0M$-58.0M$-115.0M$-75.0M$-14.0M
EPS$-24.39$-36.72$-72.12$-46.59$-8.64
Op Margin-510.9%-323.7%-11047.6%-31777.6%—

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$165.0M$225.0M$163.0M$55.0M$50.0M
Total Liabilities$261.0M$23.0M$67.0M$32.0M$41.0M
Cash$100.0M$133.0M$71.0M$25.0M$10.0M
Borrowings$2.0M$6.0M$52.0M$30.0M$28.0M

Latest News

FINEOS Announces Successful Cloud Migration of New Zealand Accident Compensation Corporation to the FINEOS Platform Business Wire · Jul 7, 2026 Exploring 3 Asian Undervalued Small Caps With Insider Activity Simply Wall St. · Jun 14, 2026 Undervalued Small Caps In Asian Markets With Insider Buying Simply Wall St. · Jun 8, 2026 Exploring 3 Undervalued Small Caps In Global With Insider Buying Simply Wall St. · Jun 8, 2026 Undervalued Asian Small Caps With Insider Action For June 2026 Simply Wall St. · Jun 1, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-31.0M$-67.0M$-75.0M$-32.0M—
Investing Cash Flow$-5.0M$-32.0M$-4.0M$1.0M—
Financing Cash Flow$0$1.0M$0$-1.0M—
Net Cash Flow$58.0M$36.0M$-62.0M$-46.0M—
Free Cash Flow$-34.0M$-83.0M$-77.0M$-32.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-2.40
FCF Yield-204.37%
Quick Ratio3.39
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BMEA $1.22 +0.00% -1.20 $88.21M 0.00%
CNTB $2.07 -1.67% -2.31 $130.02M 0.00%
EWTX $43.52 -2.03% -14.63 $4.68B 0.00%
HOWL $0.40 -3.04% -0.33 $19.54M 0.00%
IMA $5.69 +1.07% -1.49 $64.18M 0.00%

About Finch Therapeutics Group, Inc.

Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.

Finch Therapeutics Group, Inc. is headquartered in US.

Finch Therapeutics Group, Inc. (FNCH) stock trades at $9.60 with a market capitalization of $15.42M. The stock is valued at a price-to-earnings (P/E) ratio of -1.11, price-to-book of 1.70, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.00 and $16.10, and currently trades 40.4% below its 52-week high.

On profitability, Finch Therapeutics Group, Inc. generates a return on equity (ROE) of -86.83%, return on capital employed of -40.49%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.finchtherapeutics.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides